Subscribe
- VOLUNTARY ANNOUNCEMENT INITIATION OF PHASE I CLINICAL TRIAL AND COMPLETION OF FIRST PATIENT ENROLLMENT FOR TDCP ADOLESCENT AND ADULT Download
- VOLUNTARY ANNOUNCEMENT RECOMBINANT COVID-19 XBB.1.5 VARIANT VACCINE FOR INHALATION (ADENOVIRUS TYPE 5 VECTOR) INCLUDED FOR EMERGENCY USE Download
- Monthly Return of Equity Issuer on Movements in Securities Download
- VOLUNTARY ANNOUNCEMENT INITIATION OF PHASE I CLINICAL TRIAL AND COMPLETION OF FIRST PATIENT ENROLLMENT FOR RECOMBINANT ZOSTER VACCINE Download
- RESIGNATION OF CHIEF FINANCIAL OFFICER Download
- Monthly Return of Equity Issuer on Movements in Securities Download
- NOTICE OF BOARD MEETING Download
- VOLUNTARY ANNOUNCEMENT GRANT AGREEMENT OF RECOMBINANT POLIOMYELITIS VACCINE PROJECT WITH BILL & MELINDA GATES FOUNDATION Download
- THIRD QUARTERLY REPORT FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2023 Download
- Monthly Return of Equity Issuer on Movements in Securities Download
